Evidence map›Paper›PMID 36224407›Full record

ArticleMedical oncology (Northwood, London, England)2022

In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers.

Faten Eshrati Yeganeh, Amir Eshrati Yeganeh, Mahdi Fatemizadeh, Bahareh Farasati Far, Sameer Quazi, Muhammad Safdar

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Newly Synthesized CoFeInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Application of biosensors in cancers, an overview.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Faten Eshrati YeganehDepartment of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Amir Eshrati YeganehDepartment of Microbiology, Noor Dahesh Institute of Higher Education, Meymeh, Iran.
Mahdi FatemizadehDepartment of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Bahareh Farasati FarDepartment of Chemistry, Iran University of Science and Technology, Tehran, Iran.
Sameer QuaziGenLab Biosolutions Private Limited, Bangalore, Karnataka, India. colonel.quazi@gmail.com.ORCID http://orcid.org/0000-0002-1258-4088
Muhammad SafdarDepartment of Pharmacy, Gomal University, Dikhan, Pakistan.
Gomal University · PKIran University of Science and Technology · IRIslamic Azad University, Science and Research Branch · IRManchester Academic Health Science Centre · GBSadra Institute Of Higher Education · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel and specific drug delivery for in vitro cancer targeted are developed successfully by a simple one-step method. A CoFe

Indexed as

Antineoplastic AgentsMagnetite NanoparticlesNanoparticlesDrug CarriersDrug LiberationHumansLetrozoleMethionineAntineoplastic AgentsDrug CarriersLetrozoleMagnetite NanoparticlesMethionineCell lineCoFe2O4 nanoparticlesCytotoxicityDrug deliveryLetrozoleMethionine

Identifiers

PMID36224407
OpenAlexW4304809280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.